Bitan Gal, Vollers Sabrina S, Teplow David B
Center for Neurologic Diseases, Brigham and Women's Hospital, and Department of Neurology, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Biol Chem. 2003 Sep 12;278(37):34882-9. doi: 10.1074/jbc.M300825200. Epub 2003 Jul 2.
Assembly of monomeric amyloid beta-protein (A beta) into oligomeric structures is an important pathogenetic feature of Alzheimer's disease. The oligomer size distributions of aggregate-free, low molecular weight A beta 40 and A beta 42 can be assessed quantitatively using the technique of photo-induced cross-linking of unmodified proteins. This approach revealed that low molecular weight A beta 40 is a mixture of monomer, dimer, trimer, and tetramer, in rapid equilibrium, whereas low molecular weight A beta 42 preferentially exists as pentamer/hexamer units (paranuclei), which self-associate to form larger oligomers. Here, photo-induced cross-linking of unmodified proteins was used to evaluate systematically the oligomerization of 34 physiologically relevant A beta alloforms, including those containing familial Alzheimer's disease-linked amino acid substitutions, naturally occurring N-terminal truncations, and modifications altering the charge, the hydrophobicity, or the conformation of the peptide. The most important structural feature controlling early oligomerization was the length of the C terminus. Specifically, the side-chain of residue 41 in A beta 42 was important both for effective formation of paranuclei and for self-association of paranuclei into larger oligomers. The side-chain of residue 42, and the C-terminal carboxyl group, affected paranucleus self-association. A beta 40 oligomerization was particularly sensitive to substitutions of Glu22 or Asp23 and to truncation of the N terminus, but not to substitutions of Phe19 or Ala21. A beta 42 oligomerization, in contrast, was largely unaffected by substitutions at positions 22 or 23 or by N-terminal truncations, but was affected significantly by substitutions of Phe19 or Ala21. These results reveal how specific regions and residues control A beta oligomerization and show that these controlling elements differ between A beta 40 and A beta 42.
单体淀粉样β蛋白(Aβ)组装成寡聚结构是阿尔茨海默病的一个重要致病特征。使用未修饰蛋白质的光诱导交联技术可以定量评估无聚集体的低分子量Aβ40和Aβ42的寡聚体大小分布。该方法表明,低分子量Aβ40是单体、二聚体、三聚体和四聚体的混合物,处于快速平衡状态,而低分子量Aβ42优先以五聚体/六聚体单元(副核)形式存在,这些单元会自我缔合形成更大的寡聚体。在此,使用未修饰蛋白质的光诱导交联技术系统评估了34种生理相关Aβ同种型的寡聚化,包括那些含有与家族性阿尔茨海默病相关的氨基酸替代、天然存在的N端截短以及改变肽电荷、疏水性或构象的修饰的同种型。控制早期寡聚化的最重要结构特征是C端的长度。具体而言,Aβ42中41位残基的侧链对于副核的有效形成以及副核自我缔合形成更大的寡聚体都很重要。42位残基的侧链和C端羧基影响副核的自我缔合。Aβ40的寡聚化对Glu22或Asp23的替代以及N端截短特别敏感,但对Phe19或Ala21的替代不敏感。相比之下,Aβ42的寡聚化在很大程度上不受22或23位替代或N端截短的影响,但受Phe19或Ala21替代的显著影响。这些结果揭示了特定区域和残基如何控制Aβ寡聚化,并表明这些控制元件在Aβ40和Aβ42之间存在差异。